Cytosorbents shares
WebJul 22, 2024 · The Company has also granted the underwriters a 30-day option to purchase up to 789,473 additional shares of common stock at the public offering price less the … WebApr 12, 2024 · Of the 39 institutional investors that sold Cytosorbents stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Redmile Group LLC ($1.15M), Sectoral Asset Management Inc ($0.83M), State Street Corp ($0.57M), Goldman Sachs Group Inc. ($0.45M), Northern Trust Corp ($0.36M), …
Cytosorbents shares
Did you know?
WebGet the latest Cytosorbents Corp (CTSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebMar 28, 2024 · Cytosorbents Co. ( NASDAQ:CTSO – Get Rating) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.13 and traded as high as $3.38....
WebCytoSorbents aims to be in the elite company of fast growing medical device companies, with rapid growth, industry leading product gross margins in excess of 80%, and GAAP … WebApr 13, 2024 · CytoSorbents has a market capitalization of around $231 million with approximately 35.05 million shares outstanding and a short interest of about 8.8%. …
WebApr 13, 2024 · Cytosorbents is a smaller company with a market capitalization of US$389m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership... WebMar 10, 2024 · Cytosorbents Corp's market capitalization is $163.85 M by 43.64 M shares outstanding. Is Cytosorbents stock a Buy, Sell or Hold? Cytosorbents stock has …
WebApr 11, 2024 · Cytosorbents shares last traded at $3.30, with a volume of 55,181 shares traded. Wall Street Analyst Weigh In. A number of research firms recently issued reports …
WebMar 10, 2024 · Cytosorbents Corp's market capitalization is $142.78 M by 43.64 M shares outstanding. Is Cytosorbents stock a Buy, Sell or Hold? Cytosorbents stock has received a consensus rating of buy.... side effects pre workoutWebShares of CytoSorbents Corp. gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an to the company's blood … the plan crypto botsWebApr 12, 2024 · Of the 39 institutional investors that sold Cytosorbents stock in the last 24 months, the following investors and hedge funds have sold the highest volume of … side effects proton pump inhibitorsWebCytoSorb ® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed … the plan crypto reviewWebApr 11, 2024 · Shares of Cytosorbents Co. (NASDAQ:CTSO – Get Rating) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving … the plan dietWebView the latest Cytosorbents Corp. (CTSO) stock price, news, historical charts, analyst ratings and financial information from WSJ. CTSO Cytosorbents Corp. Stock Price & … the plan diet cleanseWebA. The Company and the Investor are parties to a Purchase Agreement dated as of May 5, 2010 (the “Purchase Agreement”), pursuant to which, among other things, the Company has the right to sell to the Investor, at its sole discretion, up to $6,000,000 of the Company’s common stock, par value $0.001 per share (“Common Stock”), upon the terms and … the plane 123movies